More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome

Pharmacotherapy. 2005 Jan;25(1):52-8. doi: 10.1592/phco.25.1.52.55617.

Abstract

Study objective: To compare the absorption profile of cyclosporine after preprandial administration with that after postprandial administration, and to determine which administration time resulted in a more stable absorption profile and the timing of the drug concentration that was the most reliable marker for monitoring drug absorption.

Design: Prospective analysis.

Setting: University teaching hospital in Japan.

Patients: Sixteen patients with refractory nephrotic syndrome.

Intervention: Thirteen patients received cyclosporine after breakfast (postprandial group) and eight received the drug 30 minutes before breakfast (preprandial group).

Measurements and main results: Blood cyclosporine concentration was measured 5 times serially: before administration (C 0 ) and at 1-hour intervals until 4 hours after administration of cyclosporine (C 1 -C 4 ). Also, area under the concentration-time curve from 0-4 hours (AUC 0-4 ) was calculated. Of the 13 patients in the postprandial group, six (46%) showed fair absorption and exhibited a peak concentration at C 1 or C 2 (high-absorption pattern); seven (54%) showed poor absorption and did not reach the peak concentration within the 4-hour period (low-absorption pattern). Five of the seven patients with the low-absorption pattern were switched from postprandial to preprandial administration. All patients in the preprandial administration group showed a high-absorption pattern and reached the peak cyclosporine concentration at C 1 . The C 2 value showed the best correlation with AUC 0-4 in both groups, and the C 0 parameter did not correlate with AUC 0-4 in either group.

Conclusion: Preprandial administration provided a more stable absorption profile of cyclosporine compared with postprandial administration. From the correlation with AUC 0-4 , we concluded that C 2 , and not C 0 , is a reliable marker for monitoring cyclosporine exposure.

Publication types

  • Comparative Study

MeSH terms

  • Absorption
  • Area Under Curve
  • Cyclosporine / administration & dosage
  • Cyclosporine / metabolism
  • Cyclosporine / pharmacokinetics*
  • Drug Administration Schedule
  • Fasting*
  • Hospitals, University
  • Humans
  • Middle Aged
  • Nephrotic Syndrome / diagnosis*
  • Nephrotic Syndrome / drug therapy*
  • Nephrotic Syndrome / physiopathology
  • Postprandial Period*
  • Prospective Studies
  • Severity of Illness Index*
  • Time Factors

Substances

  • Cyclosporine